Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early

BACKGROUND: Glioblastoma (GB) is the most severe form of brain cancer, with a 12-15 month median survival. Surgical resection, temozolomide (TMZ) treatment, and radiotherapy remain the primary therapeutic options for GB, and no new therapies have been introduced in recent years. This therapeutic sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Morelli, Mariangela, Lessi, Francesca, Barachini, Serena, Liotti, Romano, Montemurro, Nicola, Perrini, Paolo, Santonocito, Orazio Santo, Gambacciani, Carlo, Snuderl, Matija, Pieri, Francesco, Aquila, Filippo, Farnesi, Azzurra, Naccarato, Antonio Giuseppe, Viacava, Paolo, Cardarelli, Francesco, Ferri, Gianmarco, Mulholland, Paul, Ottaviani, Diego, Paiar, Fabiola, Liberti, Gaetano, Pasqualetti, Francesco, Menicagli, Michele, Aretini, Paolo, Signore, Giovanni, Franceschi, Sara, Mazzanti, Chiara Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483168/
https://www.ncbi.nlm.nih.gov/pubmed/36132155
http://dx.doi.org/10.3389/fonc.2022.969812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483168/
https://www.ncbi.nlm.nih.gov/pubmed/36132155
http://dx.doi.org/10.3389/fonc.2022.969812

Ejemplares similares